CCL5 and osteosarcoma: CCL5/CCR5 axis has also been proposed to affect the motility of human osteosarcoma [40] and oral cancer cells in vitro [32] and CCL5 neutralization was shown to restrict tumor progression in colorectal carcinoma [33].